• Ronald Dorenbos, Former Head, Innovation Management & Scouting, Takeda
As former Head of Innovation Management and Scouting and as a member of Takeda’s Digital Strategy team Ronald helped Takeda with its technology and innovation strategy. After obtaining MAs in Biotechnology and Molecular Biology and a PhD in Pharmaceutical Biology in the Netherlands, Ronald led research projects on Parkinson’s, Schizophrenia and the genetics of aggressive behavior, before making the transition to industry. He is frequently invited to deliver presentations and keynotes related to AI in Pharma and Healthcare and has presented at national and international events. Ronald founded the LinkedIn groups ‘AI – Artificial Intelligence’, ‘Small Molecules’, ‘Boston Biotech’ and ‘Golden Triangle Biotech’ that serve over 10,000 members.
• Chihiro Hosoya, BD/VC Head, Astellas Rx+ Business Accelerator
Chihiro Hosoya is Head of Venture Management and Business Development of Astellas Rx+ Business Accelerator LLC. Astellas Rx+ Business Accelerator LLC is an affiliate of Astellas, a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable medical solutions. With our Rx+TM strategy, we aim to create innovative healthcare solutions that combine our strengths in the prescription drug (Rx) business with innovative cutting-edge technology in different fields which would contribute to patients through Patient Journey (overall medical care, including diagnostic, preventive, therapeutic, and prognostic care) and bring new revenue streams separate from Astellas’ core Rx products. Chihiro seeks investment and partnership opportunities which would contribute to creation or advancement of Rx+ business, with high focus in medical device, digital health and surgical support. She has 15 years of industry experiences in research and Business Development in addition to Rx+ business.
• Nicholas Mourlas, Senior Director, New Ventures, Johnson & Johnson
Nick serves as Senior Director of New Ventures and Transactions at J&J Innovation, and is the Global Transaction Leader for Global Surgery and CSS within Global External Innovation. Nick focuses on medical device innovation in support of the general surgery, orthopedics, and cardiology businesses. His charge is to identify licensing, collaboration, and investment opportunities highly aligned with J&J business strategies by building relationships with entrepreneurs, venture investors, and key opinion leaders. Nick’s experience includes founding companies in orthopedics, cardiology, and radiation oncology. He was the CEO of Tarsus Medical – acquired by Integra LifeSciences (IART), and Acumen Medical – acquired by Medtronic (MDT).Dr. Mourlas holds a Ph.D. in Electrical Engineering from Stanford University where he was the John B. Simpson Innovation Fellow in the inaugural year of Stanford’s Biodesign Fellowship Program. He also received his AB in Engineering Sciences from Dartmouth College, and a BE from Dartmouth’s Thayer School.
• Rachel Rea, Director of BD & Licensing – Surgical Innovations, Medtronic
Rachel is a Director of Business Development and Licensing at Medtronic. She has been with Medtronic for almost 9 years serving both its Respiratory, Gastrointestinal & Informatics division and more recently its Surgical Innovations division. As a Director of Business Development and Licensing, Rachel is focused on opportunities to bring additional innovation to Medtronic and its patients. These opportunities could consist of licensing, distribution, investment, acquisition, etc. Rachel has a Bachelor of Science in Biomedical Engineering from the University of Miami in Miami, FL, and a Masters of Business Administration from the University of Colorado at Boulder.
• Yasuko Shusa, Manager, BD, Early Stage Technology Scouting & Alliance, Olympus Corporation of the Americas
Yasuko joined Olympus in 2011. She has nearly 20 years of professional experience in the medical device and life science fields. Her primary role at Olympus America is sourcing advanced and innovative medical device technologies and identifying companies for new partnership opportunities. Prior to joining Olympus, she was at a Corporate Venture Capital (ITX International Holdings, an Olympus subsidiary). She also worked at a Venture Capital firm which focused on the entire spectrum of life science arena. She played a pivotal role on both of the investment teams. Yasuko also has experience as an initial member of a startup company. Her broad background and knowledge of medical technology, global business development, startup, and investment help her to develop innovative approaches to achieving Olympus’s goals. She received her BSN degree from National University in Japan. Yasuko believes that finding new medical device technologies is like opening a door into new ways to create a healthier and happier society.